研究者氏名	髙原健
	タカハラキヨシ
URL
所属	藤田医科大学
部署	医学部腎泌尿器外科
職名	准教授
学位	博士（医学）
J-Global ID	201701000378350191

研究キーワード

前立腺癌 ,腎癌 ,ロボット支援手術

研究分野

ライフサイエンス / 腫瘍診断、治療学 / 前立腺癌
ライフサイエンス / 泌尿器科学 /

経歴

12 >

2018年10月

現在

藤田医科大学医学部腎泌尿器外科准教授

2017年4月

2018年9月

藤田医科大学医学部腎泌尿器外科講師

2016年9月

2017年3月

大阪医科薬科大学医学部腎泌尿器外科

2015年10月

2016年8月

大阪医科薬科大学医学部腎泌尿器外科

2013年4月

2015年9月

大阪医科薬科大学医学部腎泌尿器外科助教

学歴

2009年4月

2013年3月

大阪医科薬科大学大学院医学研究科

1993年4月

1999年3月

大阪医科薬科大学医学部医学科

論文

<3 456 7 >

Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma.

Taizo Uchimoto Tatsuo Fukushima Kazumasa Komura Wataru Fukuokaya Takahiro Adachi Takeshi Hashimoto Atsuhiko Yoshizawa Ko Nakamura Yusuke Yano Kazuki Nishimura Kyosuke Nishio Keita Nakamori Kosuke Iwatani Shutaro Yamamoto Fumihiko Urabe Keiichiro Mori Takafumi Yanagisawa Shunsuke Tsuduki Kiyoshi Takahara Teruo Inamoto Jun Miki Takahiro Kimura Yoshio Ohno Ryoichi Shiroki Shin Egawa Haruhito Azuma

BJU international 131(4) 477-485 2022年9月

OBJECTIVES: To assess the real-world clinical benefit of re-challenging chemotherapy after pembrolizumab in patients with metastatic urothelial carcinoma (mUC), as there have been several reports suggesting that programmed cell death protein-1/pro...

Editorial Comment to Does histologic subtype impact overall survival in observed T1a kidney cancers compared with competing risks? Implications for biopsy as a risk stratification tool.

Kiyoshi Takahara Ryoichi Shiroki

International journal of urology : official journal of the Japanese Urological Association 29(8) 851-852 2022年8月

Boron neutron capture therapy for urological cancers.

Kiyoshi Takahara Shin-Ichi Miyatake Haruhito Azuma Ryoichi Shiroki

International journal of urology : official journal of the Japanese Urological Association 29(7) 610-616 2022年7月

Boron neutron capture therapy is based on a nuclear reaction between the nonradioactive isotope boron-10 and either low-energy thermal neutrons or high-energy epithermal neutrons, which generate high linear energy transfer α particles and a recoil...

Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma.

Taizo Uchimoto Ko Nakamura Kazumasa Komura Wataru Fukuokaya Yusuke Yano Kazuki Nishimura Shoko Kinoshita Kyosuke Nishio Tatsuo Fukushima Keita Nakamori Tomohisa Matsunaga Takeshi Tsutsumi Takuya Tsujino Kohei Taniguchi Tomohito Tanaka Hirofumi Uehara Kiyoshi Takahara Teruo Inamoto Takahiro Kimura Shin Egawa Haruhito Azuma

Urologic oncology 40(7) 344.e11-344.e17 2022年7月

PURPOSE: Most patients with metastatic urothelial carcinoma experience no objective response to pembrolizumab and have poor overall survival (OS). Here, we investigated the prognostic value of fluctuation in the neutrophil-lymphocyte ratio (NLR) a...

Risk factors for postoperative ileus after robot-assisted radical cystectomy with intracorporeal urinary diversion.

Kenji Zennami Makoto Sumitomo Kyu Hasegawa Masaki Kozako Kiyoshi Takahara Takuhisa Nukaya Masashi Takenaka Kosuke Fukaya Manabu Ichino Naohiko Fukami Hitomi Sasaki Mamoru Kusaka Ryoichi Shiroki

International journal of urology : official journal of the Japanese Urological Association 29(6) 553-558 2022年6月

OBJECTIVES: To evaluate the risk factors for postoperative ileus in patients who underwent robot-assisted radical cystectomy with intracorporeal urinary diversion. METHODS: We retrospectively analyzed 78 patients with bladder cancer who underwent ...